Article Information
History
- May 12, 2021.
Article Versions
- You are currently viewing Version 1 of this article (May 12, 2021 - 07:43).
- Version 2 (May 14, 2021 - 08:43).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Vikash Jaiswal1,
- Danah Alquraish1,
- Shavy Nagpal2,
- Dattatreya Mukherjee*,3,
- Prakriti Singh Shrestha1,
- Diana Sanchez Velazco4,
- Prathima Guntipalli1,
- Arushee Bhatnagar1,
- Saloni Savani5,
- Eldamhalji Halilaj6 and
- Samir Ruxmohan1
- 1Larkin Community Hospital, Miami, USA
- 2The Research Institute of St. Joe’s Hamilton, Canada
- 3International School, Jinan University, P.R China
- 4Cayetano Heredia Peruvian University, Peru
- 5GMERS Medical College, Sola, Ahmedabad, India
- 6Ankara University School of Medicine, Turkey
- ↵*Corresponding Author
: Dattatreya Mukherjee, Jinan University, dattatreyamukherjee4u{at}outlook.com
Posted May 12, 2021.
INFLUENCE OF NOVEL CORONAVIRUS DISEASE (COVID-19) ON PARKINSON’S DISEASE: SYSTEMATIC REVIEW
